Literature DB >> 25527680

Primary pulmonary lymphoma in a patient with advanced AIDS.

Lokesh Shahani1, Megan McKenna2.   

Abstract

Non-Hodgkin's lymphoma (NHL) is an AIDS defining lesion and risk of NHL most likely correlates with the degree of immunosuppression from HIV. Risk of NHL is highest among patients with CD4 count <50 cells/mL. Primary pulmonary lymphoma (PPL) is an infrequent cause of AIDS-related lymphoma. The authors report a patient with advanced AIDS presenting with recurrent fever and pulmonary nodule seen on the CT scan. The patient remained febrile despite being on broad spectrum antibiotics with no clear source of infection. The patient underwent a bronchoscopy with biopsy of the pulmonary lesion which was most consistent with diffuse large B-cell lymphoma. The patient was started on dose-adjusted etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone (EPOCH) and was noted to be afebrile and a repeat CT scan few weeks later showed resolution of her pulmonary nodule. This case highlights the importance of considering NHL in patients with advanced AIDS presenting with pulmonary nodule and fever. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527680      PMCID: PMC4275741          DOI: 10.1136/bcr-2013-203265

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Modern management of non-Hodgkin lymphoma in HIV-infected patients.

Authors:  Nicolas Mounier; Michele Spina; Christian Gisselbrecht
Journal:  Br J Haematol       Date:  2006-12-01       Impact factor: 6.998

Review 2.  Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Authors:  Stefan K Barta; Xiaonan Xue; Dan Wang; Roni Tamari; Jeannette Y Lee; Nicolas Mounier; Lawrence D Kaplan; Josep-Maria Ribera; Michele Spina; Umberto Tirelli; Rudolf Weiss; Lionel Galicier; Francois Boue; Wyndham H Wilson; Christoph Wyen; Albert Oriol; José-Tomás Navarro; Kieron Dunleavy; Richard F Little; Lee Ratner; Olga Garcia; Mireia Morgades; Scot C Remick; Ariela Noy; Joseph A Sparano
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

3.  Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?

Authors:  L de Leval; J A Ferry; B Falini; M Shipp; N L Harris
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

4.  Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

Authors:  Joseph A Sparano; Jeannette Y Lee; Lawrence D Kaplan; Alexandra M Levine; Juan Carlos Ramos; Richard F Ambinder; William Wachsman; David Aboulafia; Ariela Noy; David H Henry; Jamie Von Roenn; Bruce J Dezube; Scot C Remick; Manisha H Shah; Lawrence Leichman; Lee Ratner; Ethel Cesarman; Amy Chadburn; Ronald Mitsuyasu
Journal:  Blood       Date:  2009-12-18       Impact factor: 22.113

5.  Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.

Authors:  Edgar P Simard; Ruth M Pfeiffer; Eric A Engels
Journal:  Cancer       Date:  2010-10-19       Impact factor: 6.860

6.  Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.

Authors:  C Besson; A Goubar; J Gabarre; W Rozenbaum; G Pialoux; F P Châtelet; C Katlama; F Charlotte; B Dupont; N Brousse; M Huerre; J Mikol; P Camparo; K Mokhtari; M Tulliez; D Salmon-Céron; F Boué; D Costagliola; M Raphaël
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

7.  Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Authors:  Lawrence D Kaplan; Jeannette Y Lee; Richard F Ambinder; Joseph A Sparano; Ethel Cesarman; Amy Chadburn; Alexandra M Levine; David T Scadden
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

8.  Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.

Authors:  Richard F Little; Stefania Pittaluga; Nicole Grant; Seth M Steinberg; Mark F Kavlick; Hiroaki Mitsuya; Genoveffa Franchini; Martin Gutierrez; Mark Raffeld; Elaine S Jaffe; Gene Shearer; Robert Yarchoan; Wyndham H Wilson
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

9.  AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Authors:  Robert J Biggar; Anil K Chaturvedi; James J Goedert; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2007-06-12       Impact factor: 13.506

10.  Characterization of Lymphomas in a high prevalence HIV setting.

Authors:  Hamakwa Mantina; Tracey M Wiggill; Sergio Carmona; Yvonne Perner; Wendy S Stevens
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

View more
  4 in total

1.  Utility of transbronchial lung biopsy in diagnosis of cavitary lung lesion in a patient with HIV infection.

Authors:  Lokesh Shahani
Journal:  BMJ Case Rep       Date:  2015-04-09

Review 2.  Primary Pulmonary Diffuse Large B Cell Non-Hodgkin's Lymphoma: A Case Report and Literature Review.

Authors:  Ziqiang Zhu; Wei Liu; Omar Mamlouk; James E O'Donnell; Debabrata Sen; Boris Avezbakiyev
Journal:  Am J Case Rep       Date:  2017-03-21

3.  Primary Pulmonary Diffuse Large B Cell Lymphoma Mimicking Metastasis: A Case Report and Literature Review.

Authors:  Bailong Liu; Hui Liu; Liang Guo; Yunfei Ma; Meng Guan; Min Liu
Journal:  Onco Targets Ther       Date:  2020-06-19       Impact factor: 4.147

4.  Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma.

Authors:  Huayu He; Fengwei Tan; Qi Xue; Lei Liu; Yue Peng; Guangyu Bai; Moyan Zhang; Shugeng Gao
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.